DICAM, a molecular passport for T(H)17 cell entry into the brain
SCIENCE TRANSLATIONAL MEDICINE（2022）
摘要
DICAM, a trafficking molecule preferentially expressed by T17 cells, may be a therapeutic target for treating neuroinflammation (Charabati ).
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要